Agoracom Blog Home

Posts Tagged ‘covid19’

Datametrex AI $DM.ca $DTMXF Tracks Social Media Data to Understand “Reddit” Effect $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 8:16 AM on Thursday, February 4th, 2021
  • Announced that NexaSMART allows for deepened analysis and understanding of social media influence over stock prices.
  • Nexalogy will soon add Reddit and other data sources in order to expand AI interpretation of such trends.
  • NexaSMART stands for “Social Media Automated Reporting Technology.”

Toronto, Ontario–(February 4, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that NexaSMART allows for deepened analysis and understanding of social media influence over stock prices. Nexalogy will soon add Reddit and other data sources in order to expand AI interpretation of such trends. NexaSMART stands for “Social Media Automated Reporting Technology.”

Many investor eyes have turned to the subject of discussion forums such as Reddit that can have impact on the stock market and the price rise of specific stocks, sometimes even despite poor business indicators. According to the Wall Street Journal, mainstream journalists have linked cryptocurrency, stock speculation and conspiracy theories together as a formula for volatility in markets.1

In todays environment, investors rely even more on their investments to secure a comfortable retirement. We believe it is vital for people to know what the truth is and what is fiction when searching for information online that can have a major impact on their returns.

Nexalogy, the wholly owned subsidiary of Datametrex AI Limited, has expertise in disinformation research, and is able to track phenomenon of this nature as evidenced in NexaSMART reports (Read Report Here).

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754635-datametrex-ai-tracks-social-media-data-to-understand-reddit-effect/messages/2301971#message

Datametrex $DM.ca $DTMXF Announces Investor Webinar $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 1:52 PM on Wednesday, February 3rd, 2021

Toronto, Ontario–(February 3, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that senior management will be hosting an investor update webinar on Tuesday, February 9, 2021, at 1:30 p.m. EST for a corporate update on the latest developments of the Artificial Intelligence technologies and COVID-19 test kits.

Webinar Details:

Date: Tuesday, February 9, 2021

Time: 1:30 p.m. ET

Registration Link: https://us02web.zoom.us/webinar/register/WN_Ge6setHBRAyeBLbKaUIUHQ

Datametrex plans to answer questions previously sent to [email protected] and during the webinar, at management’s discretion and subject to time constraints.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754580-datametrex-announces-investor-webinar/messages/2301880#message

Xphyto Unit $XPHY.ca $XPYHF Signs Psychedelic Deal with Applied Pharma $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:29 AM on Wednesday, February 3rd, 2021
  • Announces Psychedelic Pharmaceutical Production Agreement
  • Synthesis of pharmaceutical grade psychedelic compounds
  • Working toward regulatory approval for the commercial production process

XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories Inc. (“XPhyto Labs”), its wholly owned Alberta subsidiary, has signed an agreement (the “Agreement”) with Applied Pharmaceutical Innovation (“Applied”) for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process.

The industrial-scale production of standardized active pharmaceutical ingredients is an important part of XPhyto’s psychedelic pharmaceutical program as the Company anticipates a shortage of large-scale supply of certain approved and standardized pharmaceutical grade psychedelics.

Applied is a not-for-profit institution at the University of Alberta created to support translational drug development for industry and innovators. With an interdisciplinary team of over 30 pharmaceutical scientists, clinicians, regulatory, patent, and market experts, Applied provides industry with access to translational science in a framework that supports commercial success. This includes retention of IP and ownership of work product for the funder, focused and efficient project execution, and regulatory compliant operations.

Read More: https://agoracom.com/ir/XphytoTherapeutics

Datametrex $DM.ca $DTMXF Secures Exclusive Rights to Distribute FDA, EUA and CE Approved #COVID-19 Saliva Kit $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 8:02 AM on Wednesday, February 3rd, 2021
  • Secured exclusive rights to sell and distribute COVID-19 saliva kit manufactured by WIZCHEM CO., LTD. in Canada and Saudi Arabia, and non-exclusive rights for the United States of America, United Kingdom, and European Unions.
  • COVICHEK™ Saliva Kit is a convenient DNA and RNA saliva collection device that stabilizes DNA and RNA long term in saliva sample. The saliva collection tube clearly indicates the volume of saliva required after which the funnel is removed, and cap replaced.

Toronto, Ontario–(February 3, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has secured exclusive rights to sell and distribute COVID-19 saliva kit manufactured by WIZCHEM CO., LTD. (“WIZCHEM”) in Canada and Saudi Arabia, and non-exclusive rights for the United States of America, United Kingdom, and European Unions.

The Company signed the distribution agreement on January 28, 2021, to sell the COVICHEK™ Saliva DNA/RNA Collection Kit and COVICHEK™ Viral Transport Medium (together “COVICHEK™”) in Canada, United States, European Union, United Kingdom, and the Kingdom of Saud Arabia. The Company did not pay any consideration to the manufacturer to obtain sales rights.

COVICHEK™ Saliva Kit is a convenient DNA and RNA saliva collection device that stabilizes DNA and RNA long term in saliva sample. The saliva collection tube clearly indicates the volume of saliva required after which the funnel is removed, and cap replaced. The device is fully specified for sample transport and storage.

WIZCHEM has secured U.S. FDA EUA, CE mark certification, and is Good Manufacturing Practice (GMP) facilities compliant. These tests are manufactured the with permission from the Korean FDA based on ISO 13485, and sold globally. Each of the manufacturers’ medical devices will be submitted to Health Canada (“HC”) for approval on a fast track basis and, until such approval is granted, these tests may not be sold or used in Canada at this time.

Read more: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754512-datametrex-secures-exclusive-rights-to-distribute-fda-eua-and-ce-approved-covid-19-saliva-kit/messages/2301764#message

Datametrex $DM.ca $DTMXF Provides Update on #Ronin #Blockchain $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 8:08 AM on Tuesday, February 2nd, 2021
  • As a result of favourable cryptocurrency market, the Company has determined that it would be in the best interest of all stakeholders of Datametrex to reactivate Ronin by spinning off and raising funds directly into Ronin.

Toronto, Ontario–(February 2, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”)  is pleased to announce today that the board has completed its strategic review of Ronin Blockchain Corp. (“Ronin”).

As a result of favourable cryptocurrency market, the Company has determined that it would be in the best interest of all stakeholders of Datametrex to reactivate Ronin by spinning off and raising funds directly into Ronin.

The above actions are subject to a number of approvals including the TSX Venture Exchange, plan of arrangement to spin the entity out to our shareholders, and potentially shareholders approval. Datametrex will continue to provide updates to the market as the process progresses including information about the structure of the financing and transaction.

Read more: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754416-datametrex-provides-update-on-ronin/messages/2301559#message

Empower Clinics $CBDT.ca $EPWCF Subsidiary KAI Medical Laboratory Awarded #COVID-19 Testing & Healthcare Management Program for Five Million Square Foot Dallas Market Center, The Most Complete Wholesale Trade Resource in The World With $8 Billion USD In Annual Transactions $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:05 AM on Monday, February 1st, 2021

  • Awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center, the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.
  • DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion.

VANCOUVER BC / February 1, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens each month, developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce that KAI Medical Laboratory has been awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center (“DMC”), the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.

KAI TO PROVIDE DAILY ONSITE COVID TESTING TO KEEP FIVE MILLION SQUARE FOOT TRADE CENTER OPEN TO BUYERS AND SELLERS FROM AROUND THE WORLD

DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion. DMC markets events throughout the year attracting buyers and sellers from all 50 states and more than 80 countries, resulting in significant economic impact:

  • $8 Billion in annual wholesale transactions
  • $1.1 Billion in indirect local economic impact
  • $380 million in direct local economic impact

“We cannot recover from crises like the COVID-19 pandemic without a resilient retail sector and the market centers have a critical role in participating in that recovery,” said Harlan Crow, chairman of the company that owns DMC in a January 3, 2021 Forbes Article.

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/754316-empower-clinics-subsidiary-kai-medical-laboratory-awarded-covid-19-testing-healthcare-management-program-for-five-million-square-foot/messages/2301340#message

Datametrex $DM.ca $DTMXF Announces Another COVID-19 Test Kit Sales to Canadian Mining Company $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:59 AM on Monday, February 1st, 2021
  • Received a Purchase Order from a Canadian mining company for COVID-19 test kits manufactured by 1drop Inc., and ancillary products.
  • The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees.
  • This brings approximately $2.8M sales to date to the Canadian mining companies.

Toronto, Ontario–(February 1, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”), is pleased to announce that it has received a Purchase Order (the “PO”) from a Canadian mining company (the “Purchaser”) for COVID-19 test kits manufactured by 1drop Inc. (“1drop”), and ancillary products. The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees. This brings approximately $2.8M sales to date to the Canadian mining companies.

Under the terms of the sale to the Purchaser, Datametrex will provide 1drop COVID-19 qPCR Detection Kits, a PCR machine, an RNA extraction machine, and RNA extraction kits. Datametrex anticipates that it has a little or no upfront costs associated with the sale of the test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites.

“This further confirms Datametrex’s approach with its diverse COVID-19 product portfolio of health security products and services,” stated Marshall Gunter, CEO of Datametrex.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754315-datametrex-announces-another-covid-19-test-kit-sales-to-canadian-mining-company/messages/2301339#message

XPhyto Therapeutics $XPHY.ca $XPYHF Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 7:56 AM on Thursday, January 28th, 2021
  • Construction of commercial drug manufacturing facility in Germany
  • Four clinical studies in neurological indications in 2021
  • Development of oral biosensor and contract development & manufacturing
  • Psychedelic transdermal and sublingual drug formulation development

VANCOUVER, BC / ACCESSWIRE / January 28, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company“) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for meaningful value creation.

Further to XPhyto’s press release dated January 18, 2021, the Company’s core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine.

Regarding XPhyto’s drug formulation business, the Company is pleased to set out the strategy and milestones for 2021 of its wholly owned German subsidiary, Vektor Pharma TF GmbH (“Vektor”). Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.

“2021 is expected to be a transformative year for Vektor. We will be building on significant momentum from 2020 as we advance our drug formulation, contract development, and psychedelic business,” said Prof. Dr. Thomas Beckert, managing director of Vektor Pharma TF GmbH. “The addition of scalable in-house manufacturing capability creates the potential for significant growth across virtually all of our development and commercialization programs.”

Vektor is a German narcotics manufacturer, developer, and researcher located in the district of Biberach, Baden-Württemberg, Germany. For over a decade, the company and its team have been leaders in the design, testing and manufacture of thin film drug formulations, particularly transdermal patches and sub-lingual (oral) strips for the delivery of active pharmaceutical ingredients (“API”) for the treatment of pain and neurological conditions.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/754109-xphyto-announces-drug-formulation-strategy-and-2021-milestones-innovation-to-impact/messages/2300734#message

Loop Insights $MTRX $RACMF Appoints Former Director Of Solution Architecture At NTT DATA, Tamer Shafik, As New Chief Technology Officer To Support Loop’s Global Scale $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:42 AM on Thursday, January 28th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the Company has appointed Tamer Shafik, former Director of Solution Architecture at NTT DATA Corp of Japan (TYO:9613), as its Chief Technology Officer, effective February 8th.
  • Loop Insights CEO Rob Anson stated: “I am extremely proud that Tamer recognized the opportunity and had the confidence to make the decision to walk away from the comfort and security of his current role at a global leader in NTT Data. Tamer’s decision to join Loop as our CTO truly speaks volumes about where we are headed as a company. Having an established and proven world-class talent capable of driving our technology at a truly global commercialized scale gives me incredible confidence.”

VANCOUVER, British Columbia, Jan. 28, 2021 — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated contact tracing to the brick and mortar space, is pleased to announce the Company has appointed Tamer Shafik, former Director of Solution Architecture at NTT DATA Corp of Japan (TYO:9613), as its Chief Technology Officer, effective February 8th.

Loop Insights CEO Rob Anson stated: “I am extremely proud that Tamer recognized the opportunity and had the confidence to make the decision to walk away from the comfort and security of his current role at a global leader in NTT Data. Tamer’s decision to join Loop as our CTO truly speaks volumes about where we are headed as a company. Having an established and proven world-class talent capable of driving our technology at a truly global commercialized scale gives me incredible confidence.”

Shafik Joins Loop Insights From NTT Data As a Result of a Flourishing Partnership Between the Two Companies

On December 17th, Loop Insights first announced a partnership with NTT DATA Corp of Japan (TYO:9613) with the goal of creating new recurring revenue streams for both companies, including the integration of Loop’s automated marketing capabilities with NTT Data’s NTT Smart Platform. The partnership between Loop and NTT Data has been beneficial for both parties and led directly to Shafik’s decision to join Loop Insights.

Most recently, Shafik spent 3 years as the Director of Solution Architecture at NTT Data, the world’s eighth-largest software company with a market cap of over US$20-billion, where he excelled as a digital transformation expert.

Shafik brings over 20 years of experience working in IT and eCommerce to the Loop Insights team, including 5 years spent working with leading Canadian multinational information technology consulting and systems integration company, CGI. As a digital transformation expert, Shafik has been instrumental in leading a number of established clients to update their digital infrastructure to keep pace with modern technology.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/754102-loop-insights-appoints-former-director-of-solution-architecture-at-ntt-data-tamer-shafik-as-new-chief-technology-officer-to-support-loop-s-global/messages/2300724#message

Loop Insights $MTRX $RACMF and Empower Clinics $CBDT.ca $EPWCF Establish ‘Re-open Vancouver’ Coalition to Deploy Proven Health & Data Infrastructure In Response to #COVID-19 to Help Rebuild Vancouver’s Tourism, Travel, and Hospitality Industries $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:43 AM on Tuesday, January 26th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Partnered with Empower Clinics to establish the Re-open Vancouver coalition with the goal of obtaining an approved end-to-end COVID-19 mitigation solution that can be presented to local, Provincial and Federal Government authorities on behalf of local stakeholders to help in the re-opening of Vancouver’s travel and tourism industry, including Vancouver’s cruise industry.
  • Will lead a coalition to deploy the necessary infrastructure needed to enable the economic recovery of the local Vancouver economy.
  • Under the leadership of Loop and Empower, the Re-open Vancouver coalition will focus on a science and data-driven approach to delivering an integrated end-to-end solution worthy of re-opening Vancouver’s robust tourism industry, including its convention center and cruise ship industry.
  • According to Your Canada , Vancouver’s tourism industry generates approximately 15 million unique visitors per year.

VANCOUVER, British Columbia, Jan. 26, 2021 — Loop Insights Inc. (TSXV:MTRX OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue management solutions to physical brick and mortar operators, is pleased to announce the Company has partnered with Empower Clinics to establish the Re-open Vancouver coalition with the goal of obtaining an approved end-to-end COVID-19 mitigation solution that can be presented to local, Provincial and Federal Government authorities on behalf of local stakeholders to help in the re-opening of Vancouver’s travel and tourism industry, including Vancouver’s cruise industry.

Loop Insights and Empower Clinics will lead a coalition to deploy the necessary infrastructure needed to enable the economic recovery of the local Vancouver economy. Under the leadership of Loop and Empower, the Re-open Vancouver coalition will focus on a science and data-driven approach to delivering an integrated end-to-end solution worthy of re-opening Vancouver’s robust tourism industry, including its convention center and cruise ship industry. According to Your Canada , Vancouver’s tourism industry generates approximately 15 million unique visitors per year.

Following the Canadian federal government’s announcement that all international travelers will be required to provide proof of a negative COVID-19 test in order to enter the country, Loop and Empower feel the two companies are uniquely positioned to provide a combined solution in the form of a digital Wallet pass with bank-level security and privacy that can be offered to travelers visiting Vancouver.

Steven McAuley, Chairman, and CEO of Empower stated “Benefiting from the leadership of two local Vancouver public companies, with the support of significant private and public sector participants, Re-open Vancouver is confident it will demonstrate how crucial our efforts are to the economy of the City of Vancouver, the Province of B.C. and Canada. In partnership with Loop Insights, we have market-proven tools, services, testing products, and healthcare infrastructure to make this happen now.”

Tourism Industry Facing $3.3 Trillion In Global Losses Due to Closures

According to the United Nations Conference on Trade and Development (UNCTAD), the tourism industry stands to lose up to $3.3 trillion in revenue due to closures if the industry is to remain shuttered for a year. In an effort to prevent these losses, Loop Insights will continue to work with Empower to deploy its integrated venue management platform to protect industries in need of robust safety and security protocols. To date, the Re-open Vancouver Coalition has entered into conversations with leading stakeholders in the tourism, travel, and hospitality industries.

Loop Insights CEO Rob Anson stated: “Many key provincial stakeholders in the travel, tourism, and hospitality sector have recently reached out as a result of our most recent successes deploying Loop’s venue management platform. Operators are in desperate need of a seamless and transformative solution that kickstarts the economic recovery process. Along with Empower Clinics, we will look to work with industries’ best of breed partners to deliver a unified solution that ensures best practice considerations in regards to the health, safety, and wellbeing of local residents and tourists alike.“

Loop Insights first partnered with Empower Clinics in October 2020 to provide an end-to-end COVID-19 mitigation solution complete with venue tracing, real-time automated guest exposure notifications, and testing procedures based on published guidelines.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/753922-loop-insights-and-empower-clinics-establish-re-open-vancouver-coalition-to-deploy-proven-health-data-infrastructure-in-response-to-covid-19/messages/2300213#message